Gastrin Hormone Market: Current Analysis and Forecast (2022-2028)

The gastrin hormone market is expected to witness a significant CAGR of 5% during the forecast period (2022-2028). Gastrin hormone is a peptide hormone that stimulates the secretion of gastric acid (HCl) in the stomach. Gastric acid is required for the digestion of food, absorption of nutrients & vitamins, and keeping the body away from various infections by killing the microbes. Moreover, the rising prevalence of gastric disorders and acute gastritis increases the demand for synthetic gastrin in the healthcare industry will be expected to drive the demand for gastrin hormones over the forecast period. For instance, according to the Cleveland Clinic, acute gastritis affects about 8 out of every 1,000 people.

Some of the major companies operating in the gastrin hormone market include RayBiotech Life Inc., KareBay Biochem Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co. Ltd., VWR International LLC, Merck KGaA

Insights Presented in the Report:

"Amongst salt type, the ammonium acetate category accounted for the significant share in the market in 2020"

Based on salt type, the gastrin hormone market is segmented into ammonium acetate, trifluoroacetate, and others. Among these, the ammonium acetate category is anticipated to witness a significant growth rate during the forecast period. these drugs provide relief by improving the secretion of gastric acid. The growth of this market is mainly due to the rising cases of improper digestive or gastric problems by rising consumption of unhealthy diet, and low gastrin hormone secretion. Moreover, hypochlorhydria is a deficiency of HCL acid in the stomach. Stomach secretions are made up of hydrochloric acid, several enzymes, and a mucus coating that protects the lining of the stomach

"Amongst end-user, the hospitals category is expected to witness the significant CAGR during the forecast period"

Based on end-user, the gastrin hormone market is segmented into hospitals, specialty clinics, and others. The hospitals category is anticipated to witness a considerable growth rate during the forecast period. This is mainly due to increasing patient pool in the hospitals, rising prevalence of stomach infections, long time gastric problem such as ulcers & gastrointestinal issues. These factors are contributing to the growth of this market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 60% of respondents believed that ulcers were caused by too much stress; 17%, that eating spicy foods caused ulcers; and 27%, that a bacterial infection caused ulcers.

"North America to witness significant growth during the forecast period"

For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of North America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Rest of Asia-Pacific) and Rest of World. North America accounted for a considerable market share during the forecast period. The large hospital administration of the patients, rising demand for diagnostic devices due to the surge of obesity, high alcohol & smoking ration that also inhibit the secretion of the hormones in the body and the presence of highly skilled healthcare professionals in the region. These factors will drive the growth of the market during the forecast period in the region. For instance, according to the Association of American Medical Colleges (AAMC), around 15,469 gastroenterologists are available in the U.S. in 2019.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The gastrin hormone market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.